Tianjin, China

Bingni Liu

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 11.5

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2014-2025

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor Bingni Liu

Introduction

Bingni Liu is a prominent inventor based in Tianjin, China, known for his significant contributions to the field of pharmaceuticals. With a total of five patents to his name, Liu has made remarkable advancements in the development of therapeutic agents aimed at treating diabetes and improving metabolic health.

Latest Patents

One of Liu's latest patents is titled "Glucagon-derived peptide and use thereof." This invention provides a polypeptide derivative that exhibits a dual agonistic effect on GC/GLP-1 receptors. The polypeptide derivative effectively reduces blood glucose levels while also aiding in weight loss and improving body fat levels, demonstrating superior efficacy compared to single GLP-1 receptor agonists. Another notable patent is "Phenyl c-glucoside derivative containing deoxyglucose structure, preparation method and use thereof." This invention outlines a phenyl C-glucoside derivative that can be utilized in the preparation of medicaments for treating diabetes. The method for synthesizing this derivative is noted for its simplicity and cost-effectiveness, making it suitable for large-scale industrial production.

Career Highlights

Bingni Liu has worked at the Tianjin Institute of Pharmaceutical Research and the Tianjin Institute of Pharmaceutical Research Co., Ltd. His work at these institutions has been pivotal in advancing pharmaceutical research and development, particularly in the area of diabetes treatment.

Collaborations

Liu has collaborated with notable colleagues such as Lida Tang and Guilong Zhao, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Bingni Liu's innovative work and patents have significantly impacted the pharmaceutical industry, particularly in diabetes treatment. His contributions continue to pave the way for future advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…